On-Demand Webinar

Watch Now

Privacy is important to Medpace. By clicking below, you consent to  Medpace processing and transferring the information you provide for purposes of fulfilling your request and in connection with an existing or potential business relationship. You are also acknowledging you  have been made aware that you can unsubscribe from communications at any time. 

  • What are the current trends in successful NASH trial recruitment?
  • How can differences in epidemiology and patient management paradigms in the US vs. Europe be leveraged to improve recruitment?
  • How can differences in NASH between Western and Eastern population reflect on patients’ suitability in early/late NASH trials?
  • What are the most successful current biomarkers in NASH clinical trials?
  • What endpoints should be considered at different stages of development in Phase 2-4 trials?

Imaging & Liquid Biomarkers


© 2021 Medpace, All Rights Reserved | Privacy Policy | UK Modern Slavery Act | Terms of Use | Sitemap

In this webinar, medical and operations experts from Medpace facilitate a Q&A session with Dr. Stephen A. Harrison, an experienced Key Opinion Leader (KOL) in NASH. The presenters participate in an in-depth discussion on selected topics associated with NASH development as well as strategies and opportunities for researchers. 

Key questions that will be addressed include: